BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31487403)

  • 21. Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation.
    Epperla N; Hamadani M; Ahn KW; He F; Kodali D; Kleman A; Hari PN; Pasquini M; Fenske TS; Craig MD; Kanate AS; Bachanova V
    Biol Blood Marrow Transplant; 2018 May; 24(5):983-988. PubMed ID: 29410340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation.
    Yamasaki S; Nitta H; Kondo E; Uchida N; Miyazaki T; Ishiyama K; Kiyota M; Matsuoka H; Ichinohe T; Fukuda T; Atsuta Y; Suzumiya J; Suzuki R
    Ann Hematol; 2019 Sep; 98(9):2213-2220. PubMed ID: 31327025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation.
    Yoshimitsu M; Tanosaki R; Kato K; Ishida T; Choi I; Takatsuka Y; Fukuda T; Eto T; Hidaka M; Uchida N; Miyamoto T; Nakashima Y; Moriuchi Y; Nagafuji K; Miyazaki Y; Ichinohe T; Takanashi M; Atsuta Y; Utsunomiya A;
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):832-839. PubMed ID: 29155320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2.
    Michelis FV; Messner HA; Atenafu EG; McGillis L; Lambie A; Uhm J; Alam N; Seftel MD; Gupta V; Kuruvilla J; Lipton JH; Kim DD
    Bone Marrow Transplant; 2015 Nov; 50(11):1405-10. PubMed ID: 26168067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer.
    He Y; Zhou S; Deng F; Zhao S; Chen W; Wang D; Chen X; Hou J; Zhang J; Zhang W; Ding L; Tang J; Zhou Z
    Aging (Albany NY); 2019 Dec; 11(23):10883-10901. PubMed ID: 31799941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. M2 macrophage/microglial cells induce activation of Stat3 in primary central nervous system lymphoma.
    Komohara Y; Horlad H; Ohnishi K; Ohta K; Makino K; Hondo H; Yamanaka R; Kajiwara K; Saito T; Kuratsu J; Takeya M
    J Clin Exp Hematop; 2011; 51(2):93-9. PubMed ID: 22104307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
    Baron F; Storb R; Storer BE; Maris MB; Niederwieser D; Shizuru JA; Chauncey TR; Bruno B; Forman SJ; McSweeney PA; Maziarz RT; Pulsipher MA; Agura ED; Wade J; Sorror M; Maloney DG; Sandmaier BM
    J Clin Oncol; 2006 Sep; 24(25):4150-7. PubMed ID: 16896000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).
    Konuma T; Mizuno S; Kondo T; Yamaguchi H; Fukuda T; Uchida N; Najima Y; Kanamori H; Ota S; Nakamae H; Nakamae M; Mizuno I; Sugita J; Onishi Y; Yokota A; Takahashi S; Kanda Y; Ichinohe T; Atsuta Y; Yano S;
    Ann Hematol; 2018 Nov; 97(11):2173-2183. PubMed ID: 29978286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upfront allogeneic hematopoietic cell transplantation (HCT) versus remission induction chemotherapy followed by allogeneic HCT for acute myeloid leukemia with multilineage dysplasia: A propensity score matched analysis.
    Konuma T; Harada K; Yamasaki S; Mizuno S; Uchida N; Takahashi S; Onizuka M; Nakamae H; Hidaka M; Fukuda T; Ohashi K; Kohno A; Matsushita A; Kanamori H; Ashida T; Kanda J; Atsuta Y; Yano S;
    Am J Hematol; 2019 Jan; 94(1):103-110. PubMed ID: 30370944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation].
    Wang CY; Ren HY; Qiu ZX; Wang Y; Cen XN; Wang LH; Wang MJ; Xu WL; Wang WS; Li Y; Dong YJ; Ou JP; Liang ZY; Liu W; Wang Q
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):659-63. PubMed ID: 23978015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.
    Lin CN; Wang CJ; Chao YJ; Lai MD; Shan YS
    BMC Cancer; 2015 Mar; 15():128. PubMed ID: 25872762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Gu B; Wu X; Chen G; Ma X; Jin Z; Tang X; Han Y; Fu C; Qiu H; Sun A; Wu D
    Leuk Res; 2017 Aug; 59():41-46. PubMed ID: 28549237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation.
    Cassaday RD; Storer BE; Sorror ML; Sandmaier BM; Guthrie KA; Maloney DG; Rajendran JG; Pagel JM; Flowers ME; Green DJ; Rezvani AR; Storb RF; Press OW; Gopal AK
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):281-7. PubMed ID: 25445025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    Wang J; Jiang Q; Xu LP; Zhang XH; Chen H; Qin YZ; Ruan GR; Jiang H; Jia JS; Zhao T; Liu KY; Jiang B; Huang XJ
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):741-750. PubMed ID: 29247779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrotic focus: An important parameter for accurate prediction of a high level of tumor-associated macrophage infiltration in invasive ductal carcinoma of the breast.
    Shimada H; Hasebe T; Sugiyama M; Shibasaki S; Sugitani I; Ueda S; Gotoh Y; Yasuda M; Arai E; Osaki A; Saeki T
    Pathol Int; 2017 Jul; 67(7):331-341. PubMed ID: 28590017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.
    Bachanova V; Burns LJ; Ahn KW; Laport GG; Akpek G; Kharfan-Dabaja MA; Nishihori T; Agura E; Armand P; Jaglowski SM; Cairo MS; Cashen AF; Cohen JB; D'Souza A; Freytes CO; Gale RP; Ganguly S; Ghosh N; Holmberg LA; Inwards DJ; Kanate AS; Lazarus HM; Malone AK; Munker R; Mussetti A; Norkin M; Prestidge TD; Rowe JM; Satwani P; Siddiqi T; Stiff PJ; William BM; Wirk B; Maloney DG; Smith SM; Sureda AM; Carreras J; Hamadani M;
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1605-11. PubMed ID: 25983043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome following second allogeneic hematopoietic cell transplantation: A single-center experience.
    Aljasem HA; Messner HA; Lipton JH; Kim DDH; Viswabandya A; Thyagu S; Deotare U; Michelis FV
    Eur J Haematol; 2018 Mar; 100(3):308-314. PubMed ID: 29240253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation.
    Magenau J; Westervelt P; Khaled S; McGuirk J; Hari P; Eapen M; Becker PS; Parkin B; Braun T; Logan B; Wang H; Jagasia M; Rowley SD; Kim DD; Schechter T; Frey N; Scott B; Churay T; Lieland S; Forman S; Mineishi S
    Bone Marrow Transplant; 2017 Jan; 52(1):59-65. PubMed ID: 27427921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD204-Positive Tumor-associated Macrophages Relate to Malignant Transformation of Colorectal Adenoma.
    Taniyama D; Taniyama K; Kuraoka K; Yamamoto H; Zaitsu J; Saito A; Sakamoto N; Sentani K; Oue N; Yasui W
    Anticancer Res; 2019 Jun; 39(6):2767-2775. PubMed ID: 31177112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.